SARS-CoV-2 co-detection with influenza and human respiratory syncytial virus in Ethiopia: Findings from the severe acute respiratory illness (SARI) and influenza-like illness (ILI) sentinel surveillance, January 01, 2021, to June 30, 2022.

التفاصيل البيبلوغرافية
العنوان:	SARS-CoV-2 co-detection with influenza and human respiratory syncytial virus in Ethiopia: Findings from the severe acute respiratory illness (SARI) and influenza-like illness (ILI) sentinel surveillance, January 01, 2021, to June 30, 2022.
المؤلفون:	Shure W; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Tayachew A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Berkessa T; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Teka G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Biru M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Gebeyehu A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Woldeab A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.; The Ohio State University Global One Health initiative (GOHi), Addis Ababa, Ethiopia., Tadesse M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Gonta M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Agune A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Hailemariam A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Haile B; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Addis B; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Moges M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Lisanwork L; The Ohio State University Global One Health initiative (GOHi), Addis Ababa, Ethiopia., Gizachew L; The Ohio State University Global One Health initiative (GOHi), Addis Ababa, Ethiopia., Tigabu E; The Ohio State University Global One Health initiative (GOHi), Addis Ababa, Ethiopia., Mekuria Z; The Ohio State University Global One Health initiative (GOHi), Columbus, OH, Unites States of America., Yimer G; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Unites States of America., Dereje N; ICAP at Columbia University, Addis Ababa, Ethiopia., Aliy J; ICAP at Columbia University, Addis Ababa, Ethiopia., Lulseged S; ICAP at Columbia University, Addis Ababa, Ethiopia., Melaku Z; ICAP at Columbia University, Addis Ababa, Ethiopia., Abate E; The Ohio State University Global One Health initiative (GOHi), Addis Ababa, Ethiopia., Gebreyes W; The Ohio State University Global One Health initiative (GOHi), Columbus, OH, Unites States of America.; Department of Veterinary Preventive Medicine, Infectious Diseases, The Ohio State University, Columbus, OH, Unites States of America., Wossen M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia., Abayneh A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
المصدر:	PLOS global public health [PLOS Glob Public Health] 2024 Apr 18; Vol. 4 (4), pp. e0003093. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
نوع المنشور:	Journal Article
اللغة:	English
بيانات الدورية:	Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE
أسماء مطبوعة:	Original Publication: San Francisco, California : Public Library of Science, [2021]-
مستخلص:	SARS-CoV-2 co-infection with the influenza virus or human respiratory syncytial virus (RSV) may complicate its progress and clinical outcomes. However, data on the co-detection of SARS-CoV-2 with other respiratory viruses are limited in Ethiopia and other parts of Africa to inform evidence-based response and decision-making. We analyzed 4,989 patients' data captured from the national severe acute respiratory illness (SARI) and influenza-like illness (ILI) sentinel surveillance sites over 18 months period from January 01, 2021, to June 30, 2022. Laboratory specimens were collected from the patients and tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR) at the national influenza center. The median age of the patients was 14 years (IQR: 1-35 years), with a slight preponderance of them being at the age of 15 to less than 50 years. SARS-CoV-2 was detected among 459 (9.2%, 95% CI: 8.4-10.0) patients, and 64 (1.3%, 95% CI: 1.0-1.6) of SARS-CoV-2 were co-detected either with Influenza virus (54.7%) or RSV (32.8%) and 12.5% were detected with both of the viruses. A substantial proportion (54.7%) of SARS-CoV-2 co-detection with other respiratory viruses was identified among patients in the age group from 15 to less than 50 years. The multivariable analysis found that the odds of SARS-CoV-2 co-detection was higher among individuals with the age category of 20 to 39 years as compared to those less than 20 years old (AOR: 1.98, 95%CI:1.15-3.42) while the odds of SARS-CoV-2 co-detection was lower among cases from other regions of the country as compared to those from Addis Ababa (AOR:0.16 95%CI:0.07-0.34). Although the SARS-CoV-2 co-detection with other respiratory viral pathogens was minimal, the findings of this study underscore that it is critical to continuously monitor the co-infections to reduce transmission and improve patient outcomes, particularly among the youth and patients with ILI. Competing Interests: The authors have declared that no competing interests exist. (Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.)
References:	Viruses. 2022 Mar 17;14(3):. (PMID: 35337033) J Clin Virol Plus. 2021 Sep;1(3):100036. (PMID: 35262019) Viruses. 2023 Mar 28;15(4):. (PMID: 37112844) JAMA. 2020 May 26;323(20):2052-2059. (PMID: 32320003) BMC Med. 2020 Nov 4;18(1):346. (PMID: 33143712) J Infect. 2020 Aug;81(2):266-275. (PMID: 32473235) Front Public Health. 2023 Oct 27;11:1264632. (PMID: 37965509) J Med Virol. 2021 May;93(5):2947-2954. (PMID: 33475159) J Infect Dis. 2021 Feb 13;223(3):362-369. (PMID: 33119738) PLoS One. 2021 Apr 27;16(4):e0249992. (PMID: 33905425) Medicine (Baltimore). 2021 Mar 19;100(11):e24315. (PMID: 33725930) Int J Infect Dis. 2021 Jan;102:10-13. (PMID: 33115679) Lancet. 2011 Apr 9;377(9773):1264-75. (PMID: 21435708) Pediatr Infect Dis J. 2016 Mar;35(3):338-9. (PMID: 26658624) Ann Med Surg (Lond). 2022 May;77:103676. (PMID: 35531428) Clin Infect Dis. 2021 Apr 26;72(8):1450-1452. (PMID: 32604413) PLoS Med. 2022 Jul 19;19(7):e1004035. (PMID: 35852993) Front Microbiol. 2021 Aug 31;12:723850. (PMID: 34531842) J Med Virol. 2020 Nov;92(11):2623-2630. (PMID: 32557776) Virol J. 2021 Jun 14;18(1):127. (PMID: 34127006) J Clin Virol. 2020 Jul;128:104436. (PMID: 32447256) JAMA. 2020 May 26;323(20):2085-2086. (PMID: 32293646) J Med Virol. 2021 Feb;93(2):1119-1125. (PMID: 32770738) J Infect. 2020 Aug;81(2):e128-e129. (PMID: 32474045) Can J Infect Dis Med Microbiol. 2022 Apr 9;2022:1553266. (PMID: 35411212) Int J Epidemiol. 2021 Aug 30;50(4):1124-1133. (PMID: 33942104) J Clin Microbiol. 2015 Apr;53(4):1172-7. (PMID: 25631799) Bull World Health Organ. 2018 Feb 1;96(2):122-128. (PMID: 29403115) J Infect Dis. 2020 Sep 14;222(8):1270-1279. (PMID: 32726441) Front Med (Lausanne). 2021 Jun 25;8:681469. (PMID: 34249971) Nat Med. 2020 Aug;26(8):1205-1211. (PMID: 32546824) Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
تواريخ الأحداث:	Date Created: 20240418 Latest Revision: 20240425
رمز التحديث:	20240425
مُعرف محوري في PubMed:	PMC11025837
DOI:	10.1371/journal.pgph.0003093
PMID:	38635749
قاعدة البيانات:	MEDLINE

Full Text Finder

الوصف
تدمد:	2767-3375
DOI:	10.1371/journal.pgph.0003093